In Brief: Pharmacy Direct Network
Pharmacy Direct Network: President and CEO Robert Pfotenhauer resigns from the prescription benefit management firm, PDN announces March 10. Also leaving is VP, Secretary and General Counsel Gregory Saunders. While PDN searches for a new CEO, the company will be managed by an operating committee of the board with consultant and founding member of PDN Donald Hoscheit. PDN Chairman Ronald Ziegler (president of the National Association of Chain Drug Stores) said in the PDN press release that "the board of directors continues to emphasize the tremendous potential of PDN and intends to move forward aggressively"...
You may also be interested in...
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth